跳至主要内容
临床试验/NCT03857061
NCT03857061已完成不适用

COPDwear V2 - A Wearable and a Self-management Application for COPD Patients at Home: a Pilot Prospective Cohort Study

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Change in self-management as measured by the Mastery sub-section of the Chronic Respiratory Disease Questionnaire

研究概览

简要总结

Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with Chronic Obstructive Pulmonary Disease (COPD), which provides them with appropriate self-management tools and detects AECOPDs early to permit prompt treatment and prevent severe exacerbations requiring hospitalization.

详细描述

Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with COPD, which provides them with appropriate self-management tools and detects Acute Exacerbations of COPD (AECOPDs) early to permit prompt treatment and prevent severe exacerbations requiring hospitalization. Currently, the investigators are developing a second version of this app, WearCOPDv2. This app will incorporate features identified as being desirable from our patient interviews: 1) new sensor that was requested by patients - oxygen saturation, and 2) the app will incorporate a patient-facing interface as patients requested a method to view their data as well as access to information to learn how to manage their condition better.

Research questions:

Can an app designed for patients with COPD that includes biosensor feedback improve self-management of COPD?

What is the accuracy of our sensor data (heart rate, activity, respiratory rate, oxygen saturation, coughing, and other sounds of interest) in detecting early AECOPDs?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to speak English
  • Moderate to very severe COPD (GOLD C and D) as defined by the GOLD guidelines
  • Clinically relevant disease, as defined by a history of exacerbation in the previous 12 months
  • Previous spirometry or Pulmonary Function Test results of Forced Expiration Volume/Forced Vital Capacity (FEV1/FVC) <0.70 with an FEV1 below 80% predicted
  • Patient resides at home (not long term care residence or another hospital)

排除标准

  • Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
  • Rapid lethal disease, e.g. lung cancer, advance heart failure, end-stage renal disease
  • Any medical conditions that would impair their ability to participate in the study

结局指标

主要结局

Change in self-management as measured by the Mastery sub-section of the Chronic Respiratory Disease Questionnaire

时间窗: 6 months

Can an app designed for patients with COPD that includes biosensor feedback improve self-management of COPD? We will use the Mastery sub-section of the Chronic Respiratory Disease Questionnaire to measure our research question. Mastery is measured with a 7-point likert scale where higher scores indicate better health-related mastery.

次要结局

  • Change in self-efficacy as measured by the COPD Self-Efficacy Scale(6 months)
  • Change in Health related quality of life as measured by the St. George's respiratory questionnaire(6 months)
  • Change in symptom scale as measured by the MRC dyspnea scale(6 months)
  • Accuracy of our derived prediction algorithm to detect acute exacerbations as measured by the daily symptom score.(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Wu

General Internal Medicine Site Director

University Health Network, Toronto

研究点 (1)

Loading locations...

相似试验